Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022
2021
Events

Playback speed

10 seconds

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Combo, P+T+D, 2L T-DM1

By Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia FEATURING Jame Abraham

235 views

March 5, 2021

Comments 0

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

2021

Cleveland Clinic Expert BC Discussion: Commercial CTC Assays, ILD, R…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Miller, E. Roesch, J. Abraham

115 views

Prognostic Models & Biomarker Evaluation in mBC: Does Sacituzumab Go…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Roesch

98 views

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Ac…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Roesch

200 views

Cleveland Clinic Updates on BC Surgery: How to Refine Axilla Managem…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Miller

20 views

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Abraham

235 views

2021 Update on HER2+ MBC: Neratinib/Cape vs. Lapatinib/Cape in MBC, …

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Abraham

201 views

Cleveland Clinic Expert Discussion on BC: Chemo Benefit With Ovarian…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin, H. Moore, E. Harris, M. Kruse

24 views

Cleveland Clinic Updates on IO in mTNBC: Should We Use Atezo With Pa…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Kruse

172 views

Cleveland Clinic Updates on IO in Early Stage TNBC: Will pCR Increas…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

M. Kruse

88 views

Cleveland Clinic 2021 BC RT Updates: WBRT vs. APBI, 1-Week vs. 3-Wee…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

E. Harris

26 views

Breast Cancer Screening and Prevention: Anastrozole vs. Tamoxifen fo…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

H. Moore

454 views

BC Survivorship Updates: Diabetes Risk Reduction Diet & Survival, Im…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

H. Moore

17 views

2021 RxPONDER Study Update on Early HR+/N+ BC: How Does Chemo Affect…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

212 views

8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC…

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

115 views

2021 Update on ET in BC: Palbociclib+ET in HR+/HER2- Normal Disease …

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

J. Martin

132 views